S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Stock market today: Asia follows Wall St up on hopes Fed will ease off rate hikes
Laser breakthrough could send stock soaring 2,467% (Ad)
Is This The Collapse of Icahn Enterprises ?
20 Best Healthcare Dividend Stocks to Invest in
Laser breakthrough could send stock soaring 2,467% (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
Laser breakthrough could send stock soaring 2,467% (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What Does the Airbnb Guidance Drop Say About Travel Demand?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Stock market today: Asia follows Wall St up on hopes Fed will ease off rate hikes
Laser breakthrough could send stock soaring 2,467% (Ad)
Is This The Collapse of Icahn Enterprises ?
20 Best Healthcare Dividend Stocks to Invest in
Laser breakthrough could send stock soaring 2,467% (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
Laser breakthrough could send stock soaring 2,467% (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What Does the Airbnb Guidance Drop Say About Travel Demand?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Stock market today: Asia follows Wall St up on hopes Fed will ease off rate hikes
Laser breakthrough could send stock soaring 2,467% (Ad)
Is This The Collapse of Icahn Enterprises ?
20 Best Healthcare Dividend Stocks to Invest in
Laser breakthrough could send stock soaring 2,467% (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
Laser breakthrough could send stock soaring 2,467% (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What Does the Airbnb Guidance Drop Say About Travel Demand?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Stock market today: Asia follows Wall St up on hopes Fed will ease off rate hikes
Laser breakthrough could send stock soaring 2,467% (Ad)
Is This The Collapse of Icahn Enterprises ?
20 Best Healthcare Dividend Stocks to Invest in
Laser breakthrough could send stock soaring 2,467% (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
Laser breakthrough could send stock soaring 2,467% (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What Does the Airbnb Guidance Drop Say About Travel Demand?
NASDAQ:CALA

Calithera Biosciences (CALA) Stock Forecast, Price & News

$0.36
0.00 (0.00%)
(As of 06/1/2023 ET)
Compare
Today's Range
$0.36
$0.36
50-Day Range
$0.02
$0.37
52-Week Range
$0.01
$5.10
Volume
24,473 shs
Average Volume
206,392 shs
Market Capitalization
$1.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00

Calithera Biosciences MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
3,511.1% Upside
$13.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.11
Upright™ Environmental Score
News Sentiment
0.00mentions of Calithera Biosciences in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.55 out of 5 stars


CALA stock logo

About Calithera Biosciences (NASDAQ:CALA) Stock

Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. It also focuses on researching small molecule oncology compounds with a biomarker-driven approach that targets genetic vulnerabilities in cancer cells to deliver new therapies for patients suffering from aggressive hematologic. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.

Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

CALA Stock News Headlines

CALA - Calithera Biosciences, Inc.
Here's something only a handful of people know
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
Cala Mariolu
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Cala Llombards
Calithera Biosciences to Liquidate >CALA
See More Headlines

CALA Price History

CALA Company Calendar

Last Earnings
11/08/2021
Today
6/01/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CALA
Fax
N/A
Employees
92
Year Founded
2010

Price Target and Rating

Average Stock Price Forecast
$13.00
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+3,511.1%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-39,650,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.75 million
Book Value
($0.40) per share

Miscellaneous

Free Float
4,550,000
Market Cap
$1.75 million
Optionable
Optionable
Beta
1.18

Social Links


Key Executives

  • Susan M. MolineauxSusan M. Molineaux
    President, Chief Executive Officer & Director
  • Stephanie Wong
    CFO, Secretary & Chief Accounting Officer
  • Susan B Demo
    Senior VP-Research & Development Operations
  • Francesco Parlati
    Senior Vice President-Research
  • Christopher J. Molineaux
    Senior Vice President-Development













CALA Stock - Frequently Asked Questions

Should I buy or sell Calithera Biosciences stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Calithera Biosciences in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CALA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CALA, but not buy additional shares or sell existing shares.
View CALA analyst ratings
or view top-rated stocks.

What is Calithera Biosciences' stock price forecast for 2023?

3 brokerages have issued 1-year target prices for Calithera Biosciences' stock. Their CALA share price forecasts range from $8.00 to $18.00. On average, they anticipate the company's stock price to reach $13.00 in the next twelve months. This suggests a possible upside of 3,511.1% from the stock's current price.
View analysts price targets for CALA
or view top-rated stocks among Wall Street analysts.

How have CALA shares performed in 2023?

Calithera Biosciences' stock was trading at $3.26 at the start of the year. Since then, CALA shares have decreased by 89.0% and is now trading at $0.36.
View the best growth stocks for 2023 here
.

When is Calithera Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our CALA earnings forecast
.

How were Calithera Biosciences' earnings last quarter?

Calithera Biosciences, Inc. (NASDAQ:CALA) posted its earnings results on Monday, November, 8th. The biotechnology company reported ($3.00) earnings per share for the quarter, beating the consensus estimate of ($4.60) by $1.60. The biotechnology company had revenue of $6.75 million for the quarter. During the same quarter last year, the firm earned ($6.40) EPS.

When did Calithera Biosciences' stock split?

Calithera Biosciences's stock reverse split on Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Calithera Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX), Rigel Pharmaceuticals (RIGL), First Solar (FSLR), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).

What is Calithera Biosciences' stock symbol?

Calithera Biosciences trades on the NASDAQ under the ticker symbol "CALA."

How do I buy shares of Calithera Biosciences?

Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Calithera Biosciences' stock price today?

One share of CALA stock can currently be purchased for approximately $0.36.

How much money does Calithera Biosciences make?

Calithera Biosciences (NASDAQ:CALA) has a market capitalization of $1.75 million and generates $9.75 million in revenue each year. The biotechnology company earns $-39,650,000.00 in net income (profit) each year or ($25.60) on an earnings per share basis.

How can I contact Calithera Biosciences?

Calithera Biosciences' mailing address is 343 OYSTER POINT BLVD. SUITE 200, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.calithera.com. The biotechnology company can be reached via phone at (650) 870-1000 or via email at ir@calithera.com.

This page (NASDAQ:CALA) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -